|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| REVENUE | |||||
| COST OF REVENUE | |||||
| GROSS PROFIT | |||||
| OPERATING EXPENSES: | |||||
| Sales, marketing and operations | |||||
| General and administrative | |||||
| Technology and development | |||||
| Goodwill impairment | |||||
| Restructuring | |||||
| Total operating expenses | |||||
| LOSS FROM OPERATIONS | |||||
| Warrant fair value adjustment | |||||
| (LOSS) GAIN ON EXTINGUISHMENT OF DEBT | |||||
| INTEREST EXPENSE | |||||
| OTHER INCOME – Net | |||||
| LOSS BEFORE INCOME TAXES | |||||
| INCOME TAX EXPENSE | |||||
| Net loss | |||||
| Net loss per share attributable to common shareholders: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted-average shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...